Correction

In a publication by Minerva on 20 June 2024, it was incorrectly stated that guidelines recommend restricting the use of valproate to men and women under 55 due to its teratogenic effects. The corrected statement is actually that guidelines recommend restricting the use of valproate to men and women over 55. The error has been addressed and the corrected information can be found on the website.

Source link